The Telehealth Enhancement of Adherence to Medication (TEAM) in pediatric IBD trial: Design and methodology

Contemporary Clinical Trials

Volumn 43, Issue , 2015, Pages 105-113

  Hommel, Kevin A ^a,b   Gray, Wendy N ^c   Hente, Elizabeth ^a   Loreaux, Katherine ^a   Ittenbach, Richard F ^a,b   Maddux, Michele ^d,e   Baldassano, Robert ^f,g   Sylvester, Francisco ^h   Crandall, Wallace ^i,j   Doarn, Charles ^k   Heyman, Melvin B ^l,m   Keljo, David ^n,o   Denson, Lee A ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c AUBURN UNIVERSITY   (United States)

^d CHILDREN S MERCY HOSPITAL   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h UNIVERSITY OF NORTH CAROLINA   (United States)

ⁱ NATIONWIDE CHILDREN S HOSPITAL   (United States)

^j THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF CINCINNATI   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^o UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Adherence; Behavioral; Inflammatory bowel disease; Pediatrics; Telehealth

Indexed keywords

AZATHIOPRINE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; BEHAVIOR THERAPY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MEDICATION COMPLIANCE; METHODOLOGY; MULTICENTER STUDY; PATIENT COMPLIANCE; PATIENT EDUCATION; PEDIATRIC HOSPITAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; STUDY DESIGN; TELEHEALTH; TELEHEALTH BEHAVIORAL TREATMENT; TREATMENT OUTCOME; TREATMENT REFUSAL; VIDEOCONFERENCING; CLINICAL TRIAL; FEMALE; HEALTH SERVICE; INFLAMMATORY BOWEL DISEASES; INTERNET; MALE; PROCEDURES; PSYCHOLOGY; REMINDER SYSTEM; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; TELEPHONE; UTILIZATION;

ADOLESCENT; CHILD; FEMALE; HEALTH SERVICES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERNET; MALE; MEDICATION ADHERENCE; PATIENT EDUCATION AS TOPIC; QUALITY OF LIFE; REMINDER SYSTEMS; RESEARCH DESIGN; SELF CARE; SEVERITY OF ILLNESS INDEX; TELEMEDICINE; TELEPHONE;

EID: 84930197786     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2015.05.013     Document Type: Article

References (47)

1. Berg J.S., Dischler J., Wagner D.J., Raia J.J., Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann. Pharmacother. 1993, 27(9 Suppl.):S1-S24.
2. DiMatteo M.R. The role of effective communication with children and their families in fostering adherence to pediatric regimens. Patient Educ. Couns. 2004, 55(3):339-344.
3. Kane S., Huo D., Aikens J., Hanauer S. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am. J. Med. 2003, 114(1):39-43.
4. Gray W.N., Denson L.A., Baldassano R.N., Hommel K.A. Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms. J. Pediatr. Psychol. 2012, 37(3):282-291.
5. Rapoff M.A. Adherence to Pediatric Medical Regimens 1999, Kluwer Academic, New York.
6. Rapoff M.A., Barnard M.U. Compliance with pediatric medical regimens. Patient Compliance in Medical Practice and Clinical Trials 1991, 73-98. Raven Press, New York. J.A. Cramer, B. Spilker (Eds.).
7. DiMatteo M.R., Giordani P.J., Lepper H.S., Croghan T.W. Patient adherence and medical treatment outcomes: a meta-analysis. Med. Care 2002, 40(9):794-811.
8. Fredericks E.M., Lopez M.J., Magee J.C., Shieck V., Opipari-Arrigan L. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am. J. Transplant. 2007, 7(8):1974-1983.
9. Hommel K.A., Franciosi J., Gray W.N., Hente E., Ahrens A., Rothenberg M.E. Behavioral functioning and treatment adherence in pediatric eosinophilic gastrointestinal disorders. Pediatr. Allergy Immunol. 2012, 23:494-499.
10. Hommel K.A., Davis C.M., Baldassano R.N. Medication adherence and quality of life in pediatric inflammatory bowel disease. J. Pediatr. Psychol. 2008, 33(8):867-874.
11. Hovinga C.A., Asato M.R., Manjunath R., et al. Association of non-adherence to antiepileptic drugs and seizures, quality of life, and productivity: survey of patients with epilepsy and physicians. Epilepsy Behav. 2008, 13(2):316-322.
12. Berquist R.K., Berquist W.E., Esquivel C.O., Cox K.L., Wayman K.I., Litt I.F. Adolescent non-adherence: prevalence and consequences in liver transplant recipients. Pediatr. Transplant. 2006, 10(3):304-310.
13. Lurie S., Shemesh E., Sheiner P.A., et al. Non-adherence in pediatric liver transplant recipients - an assessment of risk factors and natural history. Pediatr. Transplant. 2000, 4(3):200-206.
14. Horwitz R.I., Viscoli C.M., Donaldson R.M., et al. Treatment adherence and risk of death after a myocardial infarction. Lancet 1990, 336(8714):542-545.
15. Balkrishnan R., Rajagopalan R., Camacho F.T., Huston S.A., Murray F., Anderson R.T. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin. Ther. 2003, 25(11):2958-2971.
16. Sokol M.C., McGuigan K.A., Verbrugge R.R., Epstein R.S. Impact of medication adherence on hospitalization risk and healthcare cost. Med. Care 2005, 43(6):521-530.
17. Logan D.E., Zelikovsky N., Labay L., Spergel J. The illness management survey: identifying adolescents' perceptions of barriers to adherence. J. Pediatr. Psychol. 2003, 28(6):383-392.
18. Hommel K.A., Davis C.M., Baldassano R.N. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm. Bowel Dis. 2009, 15(4):589-593.
19. Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J. Gastroenterol. 2008, 14(3):413-420.
20. Auvin S., Molinie F., Gower-Rousseau C., et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J. Pediatr. Gastroenterol. Nutr. 2005, 41(1):49-55.
21. Kappelman M.D., Rifas-Shiman S.L., Kleinman K., et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin. Gastroenterol. 2007, 5(12):1424-1429.
22. Zeisler B., Lerer T., Markowitz J., et al. Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitis. J. Pediatr. Gastroenterol. Nutr. 2013, 56(1):12-18.
23. Ingerski L.M., Baldassano R.N., Denson L.A., Hommel K.A. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J. Pediatr. Psychol. 2010, 35(6):683-691.
24. Hommel K.A., Baldassano R.N. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J. Pediatr. Psychol. 2010, 35(9):1005-1010.
25. Greenley R.N., Stephens M., Doughty A., Raboin T., Kugathasan S. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm. Bowel Dis. 2010, 16(1):36-41.
26. Hommel K.A., Hente E.A., Odell S., et al. Evaluation of a group-based behavioral intervention to promote adherence in adolescents with inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 2012, 24(1):64-69. 10.1097/MEG.1090b1013e32834d32809f32831.
27. Hommel K.A., Herzer M., Ingerski L.M., Hente E., Denson L.A. Individually-tailored treatment of medication nonadherence. J. Pediatr. Gastroenterol. Nutr. 2011, 53(4):435-439.
28. Stark L.J., Hommel K.A., Mackner L.M., et al. Randomized trial comparing two methods of increasing dietary calcium intake in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2005, 40(4):501-507.
29. Hommel K.A., Hente E., Herzer M., Ingerski L.M., Denson L.A. Telehealth behavioral treatment for medication non-adherence: a pilot and feasibility study. Eur. J. Gastroenterol. Hepatol. 2015, 25(4):469-473. (PMCID: PMC3703848).
30. Rapoff M.A. Adherence to Pediatric Medical Regimens 2010, Springer, New York. 2nd ed.
31. Hyams J.S., Ferry G.D., Mandel F.S., et al. Development and validation of a pediatric Crohn's Disease Activity Index. J. Pediatr. Gastroenterol. Nutr. 1991, 12(4):439-447.
32. Turner D., Otley A.R., Mack D., et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 2007, 133(2):423-432. (PMID: 17681163).
33. Markowitz J., Grancher K., Kohn N., Lesser M., Daum F., Group TPMC A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology 2000, 119(4):895-902.
34. Otley A., Smith C., Nicholas D., et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 2002, 35(4):557-563.
35. Reynolds C.R., Kamphaus R.W. Behavior Assessment System for Children (BASC) 1992, AGS, Circle Pines, MN.
36. Derogatis L.R. Brief Symptom Inventory: Administration, Scoring, and Procedures Manual 4th Edition 1993, NCS Pearson, Inc., Minneapolis, MN. 4 ed.
37. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
38. Simons L.E., Blount R.L. Identifying barriers to medication adherence in adolescent transplant recipients. J. Pediatr. Psychol. 2007, 32:831-844.
39. D'Zurilla T.J., Nezu A.M., Maydeu-Olivares A. Social Problem-Solving Inventory-Revised. Technical Manual 2002, Multi-Health Systems Inc., New York.
40. Pai A.L., Gray E., Kurivial K., Ross J., Schoborg D., Goebel J. The Allocation of Treatment Responsibility Scale: a novel tool for assessing patient and caregiver management of pediatric medical treatment regimens. Pediatr. Transplant. 2010, 14(8):993-999.
41. Robin A.L., Foster S.L. Negotiating Parent-Adolescent Conflict: A Behavioral-family System Approach 1989, Guilford Press, New York.
42. Little R.J., Rubin D.B. Statistical Analysis With Missing Data 2002, Wiley, Hoboken, NJ. 2nd ed.
43. Kraemer H.C., Kiernan M., Essex M., Kupfer D.J. How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol. 2008, 27:101-108. (Suppl.).
44. Kraemer H.C., Wilson T., Fairburn C.G., Agras W.S. Mediators and moderators of treatment effects in randomized clinical trials. Arch. Gen. Psychiatry 2002, 59:877-883.
45. Holmbeck G.N. Toward terminological, conceptual, and statistical clarity in the study of mediators and moderators: examples from the child-clinical and pediatric psychology literatures. J. Consult. Clin. Psychol. 1997, 65(4):599-610.
46. Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986, 51(6):1173-1182.
47. McGrady M.E., Hommel K.A. Medication adherence and health care utilization in pediatric chronic illness: a systematic review. Pediatrics 2013, 132(4):730-740.